USD 41.65 billion
Report ID:
SQMIG35I2117 |
Region:
Global |
Published Date: March, 2025
Pages:
219
|Tables:
177
|Figures:
72
Zoonotic Disease Treatment Market size was valued at USD 41.65 billion in 2023 and is poised to grow from USD 44.23 billion in 2024 to USD 71.57 billion by 2032, growing at a CAGR of 6.2% during the forecast period (2025-2032).
The centers for disease control and prevention estimates that tens of thousands of Americans will fall ill each year from diseases that are transmitted from animals to people. Moreover, increased urbanization and rapid population growth are projected to worsen zoonotic diseases in the years to come. The market is driven by poor sanitation rates in metropolitan areas, which is another factor. In addition, rising demand for animal proteins is probably going to result in higher consumption of animal fats, which is anticipated to fuel the market for treating zoonotic diseases. Furthermore, with millions of households owning one or more pets, pets give entertainment and companionship. Yet, the rise of the same is anticipated to be fueled by some animals carrying dangerous diseases that can be transmitted to people and cause illness. However, the lack of knowledge about this zoonotic disease in poor nations and the high cost of research and development could slow the expansion of the market for zoonotic disease treatments. Furthermore, in the upcoming years, the global market would benefit from the development of novel medications for certain animal healthcare requirements.
US Zoonotic Disease Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 41.65 billion
Largest Segment
Hospitals
Fastest Growth
Hospitals
Growth Rate
6.2% CAGR
To get more reports on the above market click here to Buy The Report
Global Zoonotic Disease Treatment Market is segmented by Disease Type, Treatment Type, Administration Route, End User and region. Based on Disease Type, the market is segmented into Rabies, Lyme Disease, Zika Virus, West Nile Virus, Hantavirus, Malaria, Tuberculosis, Relapsing Fever, Viral Hepatitis and Others. Based on Treatment Type, the market is segmented into Vaccines, Antiviral Drugs, Antibiotics, Immunoglobulins, Antibacterial Medication, Antifungal Medication and Others. Based on Administration Route, the market is segmented into Intravenous, Intramuscular and Oral. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Homecare Settings, Research Institutions and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
During the projected period, the hospital segment dominated the global Zoonotic Disease Treatment market in 2022 due to their ability to provide specialized care and support for patients with infectious diseases. Clinics and research laboratories may also be significant end-users as they are involved in the diagnosis, treatment, and prevention of zoonotic diseases.
The fastest growing segment of the zoonotic disease treatment market may be specialty clinics as the incidence of zoonotic diseases in animals continues to increase, leading to increased demand for veterinary care and treatment. As animals can serve as reservoirs for zoonotic diseases, preventing and treating these diseases in animals can also help to reduce the risk of transmission to humans.
The rabies segment dominated the global market. Rabies is a viral disease that is usually transmitted through the bite of an infected animal, such as a dog or bat. It is the dominating segment in the zoonotic disease treatment market due to the high prevalence of the disease in developing countries, where access to healthcare is limited. The market for rabies treatment is driven by the development of new and more effective vaccines and the increased use of post-exposure prophylaxis.
The lyme disease segment is the fastest growing segment. Lyme disease is a bacterial infection that is transmitted to humans through the bite of an infected tick. The disease is becoming more prevalent in North America and Europe, and as a result, the market for Lyme disease treatment is expected to grow rapidly in the coming years. The market for Lyme disease treatment is driven by the development of new antibiotics and the increasing awareness of the disease among healthcare professionals and the general public.
To get detailed analysis on other segments, Request For Free Sample Report
The North America region is anticipated to dominate the market for zoonotic disease treatment market. This dominance is owing to high prevalence of zoonotic diseases, well-established healthcare infrastructure, increasing government initiatives to control the spread of zoonotic diseases, and a growing focus on research and development of new treatments. However, The Asia-Pacific region is expected to show significant growth in the zoonotic disease treatment market due to factors such as the increasing incidence of zoonotic diseases, improving healthcare infrastructure, and rising government investments in research and development.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Request Free Customization of this report to help us to meet your business objectives.
With a wide range of businesses joining the market and creating new products and services to meet the demands of women going through Zoonotic Disease Treatment, the Zoonotic Disease Treatment market is getting more and more competitive. As the industry expands, competition is likely to heat up, forcing businesses to stand out via innovation, efficacy, and safety in order to gain market share.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global zoonotic disease treatment market analysis, increasing incidence of zoonotic diseases, rising awareness about the spread of zoonotic diseases, development of new and effective treatments, and government initiatives are several factors driving the market growth.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 41.65 billion |
Market size value in 2032 | USD 71.57 billion |
Growth Rate | 6.2% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Zoonotic Disease Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Zoonotic Disease Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Zoonotic Disease Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Zoonotic Disease Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Zoonotic Disease Treatment Market size was valued at USD 39.16 Billion in 2023 and is poised to grow from USD 41.55 Billion in 2024 to USD 66.73 Billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).
With a wide range of businesses joining the market and creating new products and services to meet the demands of women going through Zoonotic Disease Treatment, the Zoonotic Disease Treatment market is getting more and more competitive. As the industry expands, competition is likely to heat up, forcing businesses to stand out via innovation, efficacy, and safety in order to gain market share. 'Zoetis Inc.', 'Merck & Co., Inc.', 'Sanofi S.A.', 'Boehringer Ingelheim International GmbH', 'Eli Lilly and Company', 'Bayer AG', 'Virbac', 'Vetoquinol S.A.', 'Ceva Santé Animale', 'Heska Corporation', 'In January 2024, the Oral Rabies Vaccination Program (ORVP) in South Texas celebrates its 30th anniversary. This program has effectively managed and prevented rabies infections among wildlife, livestock, and people caused by domestic dog/coyote variant rabies and gray fox variant rabies. ', 'In November 2023, IDEXX Laboratories, Inc. revealed its plans to introduce the SNAP Leish 4Dx Test, a comprehensive screening test for vector-borne diseases such as canine leishmaniosis. This test will be launched in Europe and Asia beginning in February 2024. ', 'In September 2023, One Health collaborations for zoonotic disease control in Ethiopia: -EN- -FR- Les collaborations Une seule santé pour lutter contre les maladies zoonotiques en Éthiopie -ES- Actividades de colaboración en clave de Una sola salud para combatir enfermedades zoonóticas en Etiopía.'
There are several factors driving the zoonotic disease treatment market such as, increasing incidence of zoonotic diseases, rising awareness about the spread of zoonotic diseases, development of new and effective treatments, and government initiatives. Also, technological advancements and increasing investment in research and development are some of the other factors driving the market.
The prevalence of zoonotic diseases is increasing globally, driven by factors such as urbanization, deforestation, and climate change. This is driving the demand for effective treatments and vaccines in the market.
The North America region is anticipated to dominate the market for zoonotic disease treatment market. This dominance is owing to high prevalence of zoonotic diseases, well-established healthcare infrastructure, increasing government initiatives to control the spread of zoonotic diseases, and a growing focus on research and development of new treatments. However, The Asia-Pacific region is expected to show significant growth in the zoonotic disease treatment market due to factors such as the increasing incidence of zoonotic diseases, improving healthcare infrastructure, and rising government investments in research and development.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35I2117
[email protected]
USA +1 351-333-4748